Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5274 ARTÍCULOS , VIENDO DEL 691 AL 705

COVID-19, the Brain, and the Future: Is Infection by the Novel Coronavirus a Harbinger of Neurodegeneration?

Onaolapo A, Onaolapo O.

CNS Neurol Disord Drug Targets. 2022;21(9):818-829. doi: 10.2174/1871527321666211222162811.

Amphetamine-induced dopamine release and impulsivity in Parkinson's disease

Song AK, Hay KR, Trujillo P, Aumann M, Stark AJ, Yan Y, Kang H, Donahue MJ, Zald DH, Claassen DO.

Brain. 2022 Oct 21;145(10):3488-3499. doi: 10.1093/brain/awab487.

Monoamine Oxidase-B Inhibitors for the Treatment of Parkinson's Disease: Past, Present, and Future

Tan YY, Jenner P, Chen SD.

J Parkinsons Dis. 2022;12(2):477-493. doi: 10.3233/JPD-212976.

Parkinson's Disease Motor Subtypes Change with the Progression of the Disease: Results from the COPPADIS Cohort at 2-Year Follow-Up

Santos García D, Canfield H, de Deus Fonticoba T, Cores Bartolomé C, Naya Ríos L, García Roca L, Martínez Miró C, Jesús S, Aguilar M, Pastor P, Cosgaya M, García Caldentey J, Caballol N, Legarda I, Hernández Vara J, Cabo I, López Manzanares L, González Aramburu I, Ávila Rivera MA, Gómez Mayordomo V, Nogueira V, Puente V, Dotor J, Borrué C, Solano Vila B, Álvarez Sauco M, Vela L, Escalante S, Cubo E, Carrillo Padilla F, Martínez Castrillo JC, Sánchez Alonso P, Alonso Losada MG, López Ariztegui N, Gastón I, Kulisevsky J, Blázquez Estrada M, Seijo M, Rúiz Martínez J, Valero C, Kurtis M, de Fábregues O, González Ardura J, Alonso Redondo R, Ordás C, López Díaz LM, McAfee D, Martinez-Martin P, Mir P; COPPADIS Study Group.

J Parkinsons Dis. 2022;12(3):935-955. doi: 10.3233/JPD-213004.

Effects of Cannabis in Parkinson's Disease: A Systematic Review and Meta-Analysis

Urbi B, Corbett J, Hughes I, Owusu MA, Thorning S, Broadley SA, Sabet A, Heshmat S.

J Parkinsons Dis. 2022;12(2):495-508. doi: 10.3233/JPD-212923.

New Insights into the Biosensing of Parkinson's Disease Biomarkers: A Concise Review

Hosseini ES, Mohammadi S, Khodarahmi R, Fouani MH, Tavallaei O, Jaberi KR, Shabaninejad Z, Janfaza S, Yazdian-Robati R, Sajadimajd S.

Curr Med Chem. 2022;29(22):3945-3972. doi: 10.2174/0929867328666211213111812.

Adjunctive Therapies in Parkinson Disease-Have We Made Meaningful Progress?

Simuni T, Okun MS.

JAMA Neurol. 2022 Feb 1;79(2):119-120. doi: 10.1001/jamaneurol.2021.4140.

Long-term Effectiveness of Adjuvant Treatment With Catechol-O-Methyltransferase or Monoamine Oxidase B Inhibitors Compared With Dopamine Agonists Among Patients With Parkinson Disease Uncontrolled by Levodopa Therapy: The PD MED Randomized Clinical Trial

Gray R, Patel S, Ives N, Rick C, Woolley R, Muzerengi S, Gray A, Jenkinson C, McIntosh E, Wheatley K, Williams A, Clarke CE; PD MED Collaborative Group.

JAMA Neurol. 2022 Feb 1;79(2):131-140. doi: 10.1001/jamaneurol.2021.4736.

Physical Therapist Management of Parkinson Disease: A Clinical Practice Guideline From the American Physical Therapy Association

Osborne JA, Botkin R, Colon-Semenza C, DeAngelis TR, Gallardo OG, Kosakowski H, Martello J, Pradhan S, Rafferty M, Readinger JL, Whitt AL, Ellis TD.

Phys Ther. 2022 Apr 1;102(4):pzab302. doi: 10.1093/ptj/pzab302.

Occupational Therapy Interventions for People With Parkinson's Disease

Ott KR, Kolodziejczak S.

Am J Occup Ther. 2022 Jan 1;76(1):7601390010. doi: 10.5014/ajot.2022.049390.

A 66-Year-Old Man with Fever and Confusion

Ankomah P, Castillo AY, O'Neil JC, Andrews H.

NEJM Evid. 2022 Jan;1(1):EVIDmr2100037. doi: 10.1056/EVIDmr2100037. Epub 2022 Jan 10.

Outcomes Impacting Quality of Life in Advanced Parkinson's Disease Patients Treated with Levodopa-Carbidopa Intestinal Gel

Kovács N, Bergmann L, Anca-Herschkovitsch M, Cubo E, Davis TL, Iansek R, Siddiqui MS, Simu M, Standaert DG, Chaudhuri KR, Bourgeois P, Gao T, Kukreja P, Pontieri FE, Aldred J.

J Parkinsons Dis. 2022;12(3):917-926. doi: 10.3233/JPD-212979.

Double-blind cross-over pilot trial protocol to evaluate the safety and preliminary efficacy of long-term adaptive deep brain stimulation in patients with Parkinson's disease

Marceglia S, Conti C, Svanidze O, Foffani G, Lozano AM, Moro E, Volkmann J, Arlotti M, Rossi L, Priori A.

BMJ Open. 2022 Jan 3;12(1):e049955. doi: 10.1136/bmjopen-2021-049955.

Covid-19: pharmacotherapeutic insights on various curative approaches in terms of vulnerability, comorbidities, and vaccination

Kaur R, Singh S, Singh TG, Sood P, Robert J.

Inflammopharmacology. 2022 Feb;30(1):1-21. doi: 10.1007/s10787-021-00904-w. Epub 2022 Jan 3.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias